Literature DB >> 29502920

Newborn Screening: History, Current Status, and Future Directions.

Ayman W El-Hattab1, Mohammed Almannai2, V Reid Sutton3.   

Abstract

Newborn screening programs aim to achieve presymptomatic diagnosis of treatable disorders allowing for early initiation of medical care to prevent or reduce significant morbidity and mortality. Many of the conditions included in the newborn screening panels are inborn errors of metabolism; however, screening for endocrine, hematologic, immunologic, and cardiovascular diseases, and hearing loss is also included in many panels. Newborn screening tests are not diagnostic and therefore diagnostic testing is needed to confirm or exclude the suspected diagnosis. Further advancement in technology is expected to allow continuous expansion of newborn screening.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inborn errors of metabolism; Newborn screening; Tandem mass spectroscopy

Mesh:

Year:  2017        PMID: 29502920     DOI: 10.1016/j.pcl.2017.11.013

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  8 in total

Review 1.  Understanding Inborn Errors of Metabolism through Metabolomics.

Authors:  Karen Driesen; Peter Witters
Journal:  Metabolites       Date:  2022-04-27

2.  Heel prick test: maternal-fetal conditions that may have an effect on the test results in newborns admitted to the intensive care unit.

Authors:  Letícia Pinto Rodrigues; Sarah Cristina Sato Vaz Tanaka; Vanderlei José Haas; Valéria Cardoso Alves Cunali; Alessandra Bernadete Trovó de Marqui
Journal:  Rev Bras Ter Intensiva       Date:  2019-05-23

3.  Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study.

Authors:  Darryl C De Vivo; Enrico Bertini; Kathryn J Swoboda; Wuh-Liang Hwu; Thomas O Crawford; Richard S Finkel; Janbernd Kirschner; Nancy L Kuntz; Julie A Parsons; Monique M Ryan; Russell J Butterfield; Haluk Topaloglu; Tawfeg Ben-Omran; Valeria A Sansone; Yuh-Jyh Jong; Francy Shu; John F Staropoli; Douglas Kerr; Alfred W Sandrock; Christopher Stebbins; Marco Petrillo; Gabriel Braley; Kristina Johnson; Richard Foster; Sarah Gheuens; Ishir Bhan; Sandra P Reyna; Stephanie Fradette; Wildon Farwell
Journal:  Neuromuscul Disord       Date:  2019-09-12       Impact factor: 4.296

Review 4.  Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics.

Authors:  Israa T Ismail; Megan R Showalter; Oliver Fiehn
Journal:  Metabolites       Date:  2019-10-21

5.  Quantitative STAU2 measurement in lymphocytes for breast cancer risk assessment.

Authors:  Charoenchai Puttipanyalears; Sikrit Denariyakoon; Phonthep Angsuwatcharakon; Vitavat Aksornkitti; Mawin Vongsaisuwan; Sutasinee Asayut; Somchai Thanasitthichai; Narisorn Kongruttanachok; Chatchawit Aporntewan; Apiwat Mutirangura
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

6.  An integrated multiomic approach as an excellent tool for the diagnosis of metabolic diseases: our first 3720 patients.

Authors:  Ligia S Almeida; Catarina Pereira; Ruxandra Aanicai; Sabine Schröder; Tomasz Bochinski; Anett Kaune; Alice Urzi; Tania C L S Spohr; Nikenza Viceconte; Sebastian Oppermann; Mohammed Alasel; Saeedeh Ebadat; Sana Iftikhar; Eresha Jasinge; Solaf M Elsayed; Hoda Tomoum; Iman Marzouk; Anil B Jalan; Agne Cerkauskaite; Rimante Cerkauskiene; Tinatin Tkemaladze; Anjum Muhammad Nadeem; Iman Gamal El Din Mahmoud; Fawzia Amer Mossad; Mona Kamel; Laila Abdel Selim; Huma Arshad Cheema; Omid Paknia; Claudia Cozma; Carlos Juaristi-Manrique; Pilar Guatibonza-Moreno; Tobias Böttcher; Florian Vogel; Jorge Pinto-Basto; Aida Bertoli-Avella; Peter Bauer
Journal:  Eur J Hum Genet       Date:  2022-05-25       Impact factor: 5.351

7.  Utilization of archived neonatal dried blood spots for genome-wide genotyping.

Authors:  Pagna Sok; Philip J Lupo; Melissa A Richard; Karen R Rabin; Erik A Ehli; Noah A Kallsen; Gareth E Davies; Michael E Scheurer; Austin L Brown
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

8.  The Value of Cognitive Pretesting: Improving Validity and Revealing Blind Spots through the Development of a Newborn Screening Parent Experiences Survey.

Authors:  Norma-Jean Simon; Anne Atkins; Brianne Miller; Natasha Bonhomme; Beth Tarini
Journal:  Int J Neonatal Screen       Date:  2021-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.